Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.
about
Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortiumScreening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic CohortQuantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3)The Association of CYP19A1 Variation with Circulating Estradiol and Aromatase Inhibitor Outcome: Can CYP19A1 Variants Be Used to Predict Treatment Efficacy?Genetic variants in hormone-related genes and risk of breast cancer.CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole.Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes.Maximizing resources to study an uncommon cancer: E2C2--Epidemiology of Endometrial Cancer Consortium.CYP19 gene variant confers susceptibility to endometriosis-associated infertility in Chinese women.Genetic variation in sex-steroid receptors and synthesizing enzymes and colorectal cancer risk in women.Potential role of aromatase over estrogen receptor gene polymorphisms in migraine susceptibility: a case control study from North IndiaGenome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women.The aromatase gene (CYP19A1) variants and circulating hepatocyte growth factor in postmenopausal women.Genetic susceptibility factors on genes involved in the steroid hormone biosynthesis pathway and progesterone receptor for gastric cancer risk.Associations between aromatase CYP19 rs10046 polymorphism and breast cancer risk: from a case-control to a meta-analysis of 20,098 subjects.Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3).Towards a more functional concept of causality in cancer researchGenetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.Gene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women.Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors.Genotypic and allelic variability in CYP19A1 among populations of African and European ancestry8q24 risk alleles and prostate cancer in African-Barbadian men.Joint effects of colorectal cancer susceptibility loci, circulating 25-hydroxyvitamin D and risk of colorectal cancer.Genetic polymorphisms in estrogen-related genes and the risk of breast cancer among Han Chinese women.The CYP19 RS4646 polymorphism IS related to the prognosis of stage I-II and operable stage III breast cancerThe association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort.Variation in the CYP19A1 gene and risk of colon and rectal cancer.Genetic variation in the sex hormone metabolic pathway and endometriosis risk: an evaluation of candidate genes.Associations between CYP19A1 polymorphisms, Native American ancestry, and breast cancer risk and mortality: the Breast Cancer Health Disparities StudyVariations in sex hormone metabolism genes, postmenopausal hormone therapy and risk of endometrial cancerVariants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer's disease in women with down syndrome.S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.Polymorphisms in the maternal sex steroid pathway are associated with behavior problems in male offspring.Alcohol-related breast cancer in postmenopausal women - effect of CYP19A1, PPARG and PPARGC1A polymorphisms on female sex-hormone levels and interaction with alcohol consumption and NSAID usage in a nested case-control study and a randomised controlInteraction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer.Estrogen metabolism and exposure in a genotypic-phenotypic model for breast cancer risk prediction.CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancerPlasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole.Identification of a CYP19 Gene Single-Nucleotide Polymorphism Associated with a Reduced Risk of Coronary Heart Disease.
P2860
Q24614574-4D7A64E2-3229-40DF-ABFD-15B52664EFC9Q24656096-C40B8689-ABE4-4C2B-9A25-D355A671B94AQ24656179-0D8F65F7-F90D-49BD-ABCF-F95ABA499C4BQ30234511-258DA935-EE59-44BA-B9CA-451E51A5AB5DQ31126135-3138FB42-0500-4B41-9C24-87F158467319Q33616702-084EF4A9-C156-4D92-BC42-2EA49A9EFAFBQ33694817-B576CFA8-D82C-45AD-B897-54F5D73D3AAAQ33829174-1729A3C6-062C-4A54-8981-024B5ABB1629Q33844582-F99E9F5F-404A-4531-940E-0BDFFA7585DAQ33844858-FA96E99B-E36F-4DCA-8D22-1483182FE9E8Q33862850-A9DA7130-28B3-43B7-9BD4-55A2A054AE14Q34236887-A80E5741-806A-4CD9-932C-C4C44EF22A75Q34295620-7B68DD2C-E182-4734-ADF8-D1D1AE8D5C82Q34359484-3330DE1E-4800-47D0-A76F-11D9882DC079Q34460484-0EE552B9-F4FB-4E41-A5B8-FAF97ABAE53FQ34558902-46D5AA66-3450-43E8-A25C-174DA5CA1F31Q34622559-299A1C8D-50AE-4418-BC0D-76CD2AA2BF45Q34793895-4ACF950A-DFA6-4A99-A186-1135B81611B5Q34927615-803C7657-F8C9-4690-A1D7-576CD14FCAC3Q35000723-54E088EA-EB3F-4268-A239-5F15CA4A84E4Q35029533-E876125C-7625-490D-AE60-057DBE1EABCAQ35043868-D6F8E895-2188-4BF9-878B-143FFCD35681Q35064747-714ADB6C-72D0-458E-84B7-045D54B8C1D8Q35132050-166928FD-70D2-4B69-879A-917C8EF2C6CDQ35139194-46809396-8DF3-4198-8036-5CFE2618241CQ35202833-D29BD678-78E5-4BE9-8DD4-38F4692D7C57Q35558999-CC07B11B-B5D0-4D12-AE09-CC8437079F98Q35576313-2C84EB87-36B8-4308-9CFB-4761B2D2CE79Q35587188-E8C6F45E-4128-4545-9509-1AE5D72CD20EQ35619090-CFA2FDFF-6AFF-4142-A450-F9934A706008Q35705758-8C21ACBD-F4E5-4419-9431-D7D9AD1EB0A3Q35748499-EC25A923-D4C4-4472-B4F5-0749CD594767Q35854143-A051E0D2-86E0-479F-8AEC-5FC5D30E25ACQ35911273-D90598AD-BE82-46C9-8778-308F183B2D12Q35996458-ADE276DB-F9DF-4FAC-A478-FAEDB2C218DDQ36294458-F8AFDC32-DCD3-4F64-8DA2-6085934B5FB2Q36322483-55B8C440-191E-420E-A9AD-2698CFCF5C6EQ36419325-EDA28A79-8252-4618-BC95-6E77841103B1Q36484937-D78C7695-8BCF-41AF-BA41-576CEEDECE72Q36549285-66C88D85-7F7E-403E-93CF-929CD5863B82
P2860
Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Genetic variation at the CYP19 ...... risk in postmenopausal women.
@en
Genetic variation at the CYP19 ...... risk in postmenopausal women.
@nl
type
label
Genetic variation at the CYP19 ...... risk in postmenopausal women.
@en
Genetic variation at the CYP19 ...... risk in postmenopausal women.
@nl
prefLabel
Genetic variation at the CYP19 ...... risk in postmenopausal women.
@en
Genetic variation at the CYP19 ...... risk in postmenopausal women.
@nl
P2093
P50
P1433
P1476
Genetic variation at the CYP19 ...... risk in postmenopausal women.
@en
P2093
Daniel O Stram
Eugenia E Calle
Gilles Thomas
Joel N Hirschhorn
Laure Dossus
Laurence N Kolonel
Malcolm C Pike
Michael J Thun
Noël Burtt
Petra H Peeters
P304
P356
10.1158/0008-5472.CAN-06-4123
P407
P50
P577
2007-02-26T00:00:00Z